Octagon Capital Advisors »

Poseida Therapeutics I shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.3M 736k 3.19

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Alpine Immune Sciences (ALPN)
Dianthus Therapeutics (DNTH)
Verona Pharma Sponsored Ads (VRNA)
Dyne Therapeutics (DYN)
Arrivent Biopharma
Insmed Com Par $.01 (INSM)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Eyepoint Pharmaceuticals Com New (EYPT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Bridgebio Pharma (BBIO)
Mind Medicine Mindmed Com New (MNMD)
IsoRay (CATX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Octagon Capital Advisors

Top funds holding Poseida Therapeutics I

FMR
Pentwater Capital Management
BlackRock
Boxer Capital
Silverarc Capital Management
Vanguard Group
Geode Capital Management
State Street Corporation
Aisling Capital Management
William Blair $ Company
Jacobs Levy Equity Management
Octagon Capital Advisors
Millennium Management
Atom Investors
Dimensional Fund Advisors

View all funds holding Poseida Therapeutics I